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Original Investigations
Free-breathing Pulmonary 1H and
Hyperpolarized 3He MRI:
Comparison in COPD and Bronchiectasis
Dante P. I. Capaldi, BSc, Khadija Sheikh, BSc, Fumin Guo, MEng, Sarah Svenningsen, BMSc,
Roya Etemad-Rezai, MD, FRCPC, Harvey O. Coxson, PhD, Jonathon A. Leipsic, MD,
David G. McCormack, MD, FRCPC, Grace Parraga, PhD
Rationale and Objectives: In this proof-of-concept demonstration, we aimed to quantitatively and
qualitatively compare pulmonary ventilation abnormalities derived from Fourier decomposition of
free-breathing 1H magnetic resonance imaging (FDMRI) to hyperpolarized 3He MRI in subjects with
chronic obstructive pulmonary disease (COPD) and bronchiectasis.
Materials and Methods: All subjects provided written informed consent to a protocol approved by a
local research ethics board and Health, Canada, and they underwent MRI, computed tomography
(CT), spirometry, and plethysmography during a single 2-hour visit. Semiautomated segmentation
was used to generate ventilation defect measurements derived from FDMRI and 3He MRI, and these
were compared using analysis of variance and Pearson correlations.
Results: Twenty-six subjects were evaluated including 12 COPD subjects (67  9 years) and 14 bron-
chiectasis subjects (70  11 years). For COPD subjects, FDMRI and 3He MRI ventilation defect percent
(VDP) was 7  6% and 24  14%, respectively (P < .001; bias = 16  9%). In COPD subjects, FDMRI
was significantly correlatedwith 3HeMRI VDP (r = .88; P = .0001), 3HeMRI apparent diffusion coefficient
(r = .71; P < .05), airways resistance (r = .60; P < .05), and RA950 (r = .80; P < .01). In subjects with bron-
chiectasis, FDMRI VDP (5  3%) and 3He MRI VDP (18  9%) were significantly different (P < .001) and
not correlated (P > .05). The Dice similarity coefficient (DSC) for FDMRI and 3He MRI ventilation was
86  7% for COPD and 86  4% for bronchiectasis subjects (P > .05); the DSC for FDMRI ventilation
defects and CT RA950 was 19  20% in COPD and 2  3% in bronchiectasis subjects (P < .01).
Conclusions: FDMRI and 3He MRI VDP were strongly related in COPD but not in bronchiectasis sub-
jects. In COPD only, FDMRI ventilation defects were spatially related with 3He ventilation defects and
emphysema.
Key Words: Fourier decomposition; magnetic resonance imaging; bronchiectasis; chronic obstructive
pulmonary disease.
ªAUR, 2014
C
hronic obstructive pulmonary disease (COPD) is
diagnosed and disease severity stratified based on
irreversible airflow obstruction measured using
spirometry. Airflow obstruction, symptoms, and exercise
capacity measurements in COPD are related to both paren-
chyma destruction (emphysema) and airway remodeling
(airways disease and bronchiectasis) (1,2). Although
spirometry is relatively easy to implement, reproducible, and
inexpensive, it can only provide a global measure of lung
function and is weakly predictive of COPD progression, as
well as insensitive to early disease stages (3–5). The
limitations of spirometry measurements of COPD have
motivated the development of thoracic imaging approaches
to provide direct and regional measurements of the
underlying pathologic features of COPD—airways disease
and emphysema.
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High-resolution computed tomography is the clinical im-
aging tool of choice for visualizing and quantifying airways
disease (6,7) and emphysema (8–10) in patients with COPD.
Emphysema can be quantified automatically based on
thresholds of the CT density histogram (<950 Hounsfield
units [HU]) (8,10,11). Thoracic CT estimates of airways
disease can also be generated using measurements of airway
wall area percent (WA%) and lumen area (LA). Indirect
measurements of airways disease include CT measurements
of gas trapping using densitometry thresholds (856 HU)
on expiratory CT images (12) or parametric response maps
using coregistered inspiratory and expiratory CT (13). Finally,
bronchiectasis can be readily observed in thoracic CT in up to
50% of patients with severe COPD (14,15), and this is
typically identified by enlarged bronchial diameters and
evidence of significant mucous plugging.
Pulmonary magnetic resonance imaging (MRI) using
inhaled hyperpolarized 3He or 129Xe gas also provides a way
to visualize regional ventilation abnormalities and lung micro-
structure in subjects with COPD (16–25). Ventilation
abnormalities may be quantified using the ventilation defect
percent (VDP), that represents the volume of ventilation
defects normalized to the thoracic cavity (24,26). Although
rapid (8–15 seconds acquisition time) and well tolerated,
inhaled noble gas MRI is dependent on polarized gas and
multinuclear magnetic resonance imaging hardware. An
alternative approach that exploits Fourier decomposition of
free-breathing pulmonaryMRI (FDMRI) was first developed
by Bauman et al. (27) at 1.5 T. This method provides a way to
generate quantitative pulmonary maps of ventilation and
perfusion using fast pulmonary MRI acquisitions of free-
breathing 1H MRI and nonrigid registration (27–33).
FDMRI was recently compared and validated with single-
photon emission computed tomography (SPECT)-CT (28)
and 3He MRI (30) in a porcine model.
Until now, FDMRI has not been evaluated in subjects with
COPD or bronchiectasis, nor at 3 Twhere there is diminished
signal intensity at higher field strengths owing to T2* effects
(34). Hence, our objective was to generate FDMRI (first
developed at 1.5 T) and 3He MRI ventilation measurements
acquired at 3 T in subjects with COPD or bronchiectasis. We
hypothesized that ventilation defects measured using FDMRI
and 3He MRI would be spatially and quantitatively correlated
in subjects with COPD and those with bronchiectasis.
MATERIALS AND METHODS
Study Subjects
All subjects were previously diagnosed with COPD or bron-
chiectasis by a pulmonologist and provided written informed
consent to the study protocol approved by a local research
ethics board and Health Canada. Subjects with COPD were
classified according to the Global initiative for chronic
Obstructive Lung Disease (GOLD) grades (1). COPD sub-
jects were ex-smokers aged between 50 and 80 years and
with a smoking history of $10 pack years. Subjects with
bronchiectasis were ex-smokers (n = 4) and never-smokers
(n = 10) aged between 40 and 85 years. An expert chest radi-
ologist (>20 years experience) qualitatively examined CT data
for evidence of bronchiectasis and emphysema.
Pulmonary Function Tests
Spirometry and whole-body plethysmography were per-
formed using a body plethysmograph (MedGraphics Corpo-
ration, St. Paul, MN) to measure the forced expiratory
volume in 1 second, forced vital capacity, and static lung
volumes including total lung capacity, inspiratory capacity, re-
sidual volume, and functional residual capacity (FRC), air-
ways resistance (Raw), and the diffusing capacity of lung for
carbon monoxide (DLCO) using the attached gas analyzer.
All measurements were performed according to the American
Thoracic Society guidelines (35).
Image Acquisition
MRI was performed with a whole-body 3 T Discovery
MR750 system (General Electric Health Care, [GEHC] Mil-
waukee, WI) capable of performing broadband imaging. All
MR images were acquired in the coronal slice orientation.
Conventional 1H MRI was performed 5 minutes before
hyperpolarized 3He MRI. Subjects were instructed to main-
tain normal tidal breathing and then from FRC inhale a 1.0 L
mixture of 4He/N2. For the purposes of this study and to aid
direct comparisons, all MRI and CT images were acquired at
FRC + 1.0 L for consistency. By having all subjects inhale
1.0 L of gas after passive expiration, we ensured consistent
lung volumes across all imaging methods. We also note that
to truly capture the same lung volume consistently, our
approach of using a measured volume for inhalation is
straightforward and easily undertaken even supine in the
CT or MR scanner. 1H MRI was acquired with subjects in
breath-hold position using a whole-body radiofrequency
coil and a 1H fast-spoiled gradient-recalled echo (FGRE)
sequence with a partial echo (total data acquisition
time = 12 seconds; repetition time [TR]/echo time
[TE]/flip-angle = 4.3 ms/1.0 ms/30; field-of-view
[FOV] = 40  40 cm; matrix = 128  80 [zero-padded to
128  128]; partial echo percent = 62.5%; bandwidth
[BW] = 62.50 kHz; number of excitations [NEX] = 1; num-
ber of slices = 14; slice thickness = 15 mm). For all MRI
breath-hold maneuvers, oxygen saturation (SPO2) was contin-
uously monitored using a digital pulse oximeter.
Hyperpolarized 3He MRI was performed using a single-
channel rigid elliptical transmit-receive chest coil (RAPID
Biomedical, Rimpar, Wuerzburg, Germany). A polarizer sys-
tem (HeliSpin; Polarean, Durham, NC) was used to polarize
the 3He gas, which achieved polarization levels of approxi-
mately 40%. Doses of 5 mL/kg of body weight were diluted
with medical-grade N2 gas (Spectra Gases, Branchburg, NJ)
and administered in 1.0 L Tedlar bags (Jensen Inert Products,
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Coral Springs, FL). Hyperpolarized 3He ventilation images
were acquired with subjects in breath-hold position after
inspiration of a 1.0 L 3He/N2 mixture using an FGRE
method with a partial echo (total data acquisition time = 10
seconds; TR/TE/flip-angle = 3.8 ms/1.0 ms/7; FOV =
40  40 cm; matrix = 128  80 (zero-padded to 128  128);
partial echo percent = 62.5%; BW = 62.50 kHz; NEX = 1;
number of slices = 14; slice thickness = 15mm). The flip angle
was determined using a constant flip-angle approach where
flip angle (a) depends on the number of phase encoding
steps (Y-gradient steps). Thus, a ¼ tan1 ﬃﬃﬃﬃﬃﬃﬃﬃﬃ2=Np , where N
was the number of Y-gradient steps. Therefore, for this
pulse sequence, where there are 128 Y-gradient steps, a
7.12 flip angle was used. Hyperpolarized 3He diffusion-
weighted images were acquired using an FGRE sequence
with centric k-space sampling (total data acquisition
time = 14 seconds; TR/TE/flip-angle = 6.8 ms/4.5 ms/8;
FOV = 40  40 cm; matrix = 128  128;
BW = 62.50 kHz; NEX = 1; number of slices = 7; slice
thickness = 30 mm). Two interleaved images were acquired
with and without additional diffusion sensitization
(G = 1.94 G/cm; b = 1.6 s/cm2; rise-and-fall time = 0.5 ms;
gradient duration = 0.46 ms; diffusion time = 1.46 ms).
Dynamic-free tidal-breathing 1H MRI was acquired over a
period of 125 seconds at a rate of four frames per second using
an optimized balanced steady state–free precession sequence
and respiratory bellows. We used a fast imaging using steady
state pulse sequence [FIESTA; GEHC] with total data acqui-
sition time = 125 seconds; TE/TR/flip-angle = 0.6 ms/
1.9 ms/15; FOV = 40  40 cm; matrix = 256  256;
BW = 250 kHz; NEX = 1; number of phases = 500; slice
thickness = 15 mm), and a 32-channel torso coil (GEHC).
A single coronal slice was obtained with slice
thickness = 15 mm. The number of phases refers to the num-
ber of images acquired from one specific location over time. In
other words, we acquired multiple frames of one single coro-
nal slice over a certain time span. The slice was prescribed on
an axial localizer and was positioned slightly posterior to the
cardiac silhouette in an effort to eliminate artifacts due to car-
diac motion but allow visualization of the aorta.
CTwas acquired using a 64-slice LightSpeed VCT scanner
(GEHC) at FRC + 1.0 L of N2 gas using a spiral acquisition
(detector configuration = 64  0.625 mm; peak x-ray tube
voltage = 120 kVp; effective x-ray tube current = 100 mA;
x-ray tube rotation time = 500 ms; pitch = 1.0). Image recon-
struction was performed using a standard convolution kernel
of 1.25 mm.
Image Analysis
Segmentation of 3He MRI and FDMRI ventilation was per-
formed using custom software generated using MATLAB
R2013a (Mathworks, Natrick, MA), as previously described
(26). 3He MRI apparent diffusion coefficient (ADC) maps
were generated as previously described (36). The relative area
of the CT density histogram with attenuation values <950
HU (RA950) was determined using MATLABR2013a (Math-
works). Pulmonary Workstation 2.0 (VIDA Diagnostics Inc.,
Coralville, IA) was used to quantify WA% and LA.
Image analysis of dynamic free-breathing 1HMRI was per-
formed using MATLAB R2013a (Mathworks). Nonrigid
registration was used to coregister the temporal series of
tidal-breathing 1H MRI slices using a modality independent
neighborhood descriptor deformable registration method
(37). A specific reference image was used so that the corre-
sponding lung volume was consistent with 3He MRI
volumes. Pulmonary voxel intensities from the registered
free-breathing 1H MRI were aligned along a time axis, and
discrete Fourier transforms were performed on the signal
intensity oscillation pattern. The frequency of the first venti-
lation harmonic (corresponding to the respiratory rate) was
determined for every voxel, the magnitude of which was
used to generate a ventilation map.
The Dice similarity coefficient (DSC) (38) was used to
quantify the regional overlap for 3He MRI and FDMRI
ventilation, as well as the spatial relationship of CT RA950
density maps with FDMRI ventilation defect volume.
Statistics
Independent t tests, tests for normality (determined with a
Shapiro–Wilk test), and analysis of variance with post hoc
analysis using the Holm–Bonferroni correction were per-
formed using SPSS Statistics, V22.0 (SPSS Inc., Chicago,
IL). Pearson correlation coefficients (r) were used to deter-
mine the correlation between measurements using SPSS Sta-
tistics, V22.0 (SPSS Inc.). Measurement agreement was
TABLE 1. Subject Demographic and Pulmonary Function
Measurements
Mean (SD)
All
(n = 26)
Bronchiectasis
(n = 14)
COPD
(n = 12)
Significant
Difference
(P Value)
Age, years 69 (10) 70 (11) 67 (9) .5
Male, n 11 4 7 —
BMI, (kg$m2) 25 (4) 23 (4) 27 (4) .02
Pack years 31 (40) 4 (10) 63 (39) <.001
FEV1, %pred 64 (22) 68 (22) 60 (23) .4
FVC, %pred 82 (22) 73 (20) 91 (22) .04
FEV1/FVC, % 60 (16) 70 (12) 50 (14) .001
TLC, %pred 107 (18) 98 (14) 117 (16) .003
RV/TLC, % 51 (10) 54 (11) 49 (9) .3
Raw, %pred 138 (41) 135 (48) 141 (33) .7
DLCO, %pred 57 (19) 60 (18) 53 (21) .3
BMI, body mass index; COPD, chronic obstructive pulmonary dis-
ease; DLCO, diffusing capacity of lung for carbon monoxide; FEV1,
forced expiratory volume in 1 second; FVC, forced vital capacity;
%pred, percent of predicted value; Raw, airways resistance; RV, resid-
ual volume; SD, standard deviation; TLC, total lung capacity.
Significant difference between subgroups (P < .05) determined by
the analysis of variance.
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evaluated using the Bland–Altman method using GraphPad
Prism v6.0 (GraphPad Software Inc., La Jolla, CA). Correla-
tion coefficients were compared using the Fisher z0 transfor-
mation for each r value (21). Results were considered
significant when the probability of two-tailed type I error
was <5% (P < .05).
RESULTS
Table 1 shows the demographic and pulmonary function test
measurements for all subjects (69 10 years), as well as the 12
subjects with COPD (67 9 years) and 14with bronchiectasis
(70  11 years). For subjects with COPD, three were GOLD
grade I, four were GOLD grade II, and five were GOLD
grades III/IV. CTevidence of emphysema only was reported
in seven subjects with COPD, and there was CTevidence of
both emphysema and bronchiectasis in five subjects with
COPD.
Figure 1 shows coronal FDMRI and 3He MRI ventilation
registered to the 1H MRI of the thorax, as well as RA950 and
3He ADC maps for two subjects representative of COPD and
two subjects representative of bronchiectasis. As shown in
Figure 1. Ventilation and computed tomography (CT) imaging for representative COPD and bronchiectasis subjects. Free-breathing 1H mag-
netic resonance imaging (FDMRI) inmagenta coregistered with 1HMRI. 3HeMRI static ventilation in aqua coregistered with 1HMRI. CT density
masks where yellow = attenuation <950 Hounsfield units (RA950) and 3He MRI apparent diffusion coefficient maps, both reflective of emphy-
sema for subjects with chronic obstructive pulmonary disease (S1 and S2) and bronchiectasis (S3 and S4). ADC, apparent diffusion coefficient;
COPD, chronic obstructive pulmonary disease; CT, computed tomography; FDMRI, free-breathing 1Hmagnetic resonance imaging;MRI,mag-
netic resonance imaging; RA950, relative area of the lung with attenuation values <950 HU.
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Figure 1, for all four subjects, there were qualitatively similar
ventilation patterns derived from FDMRI and 3He MRI. In
subjects with COPD, regional ventilation defects were also
qualitatively similar to regional emphysema apparent in the
RA950 density maps and the brighter regions of
3He MRI
ADC maps.
Table 2 provides imaging measurements for subjects with
COPD and bronchiectasis. FDMRI (94  4%) and 3He
MRI (79 12%) ventilation measurements were significantly
different (P < .001). FDMRI VDP (6  4%) was also signif-
icantly different than 3He MRI VDP (21  12%; P < .001).
As expected, 3He MRI ADC was significantly greater in sub-
jects with COPD as compared to those with bronchiectasis
(P < .001), and all CT measurements (RA950, WA%, and
LA) were significantly greater in subjects with COPD as
compared to those with bronchiectasis.
TABLE 2. Imaging Measurements
Mean (SD) All (n = 26) Bronchiectasis (n = 14) COPD (n = 12) Significant Difference (P Value)
FDMRI Ventilation, % 94 (4) 95 (3) 93 (6) .3
3He MRI Ventilation, % 79 (12) 82 (9) 76 (14) .2
FDMRI VDP, % 6 (4) 5 (3) 7 (6) .3
3He MRI VDP, % 21 (12) 18 (9) 24 (14) .2
3He MRI ADC, cm2/s 0.35 (0.13) 0.27 (0.05) 0.43 (0.12) <.001
CT RA950, % 5 (7) 2 (3) 9 (8) .005
CT WA, % 57 (2) 58 (2) 56 (2) .009
CT LA, mm2 46 (14) 40 (10) 53 (15) .01
ADC, apparent diffusion coefficient; COPD, chronic obstructive pulmonary disease; CT, computed tomography; FDMRI, free-breathing 1H
magnetic resonance imaging; LA, lumen area; MRI, magnetic resonance imaging; RA950, relative area of the lung with attenuation
values <950 HU; SD, standard deviation; VDP, ventilation defect percent; WA, wall area.
Significant difference between groups (P < .05) determined by the analysis of variance.
Figure 2. Correlations for free-breathing
1H magnetic resonance imaging (FDMRI)
with 3He MRI and computed tomography
(CT) relative area of the lung with attenua-
tion values <950 HU (RA950). (a) FDMRI
ventilation defect percent (VDP) linear
regression with 3He MRI VDP (chronic
obstructive pulmonary disease [COPD],
r = 0.88; r2 = 0.78; P = .0001; y = 0.35x –
1.07 and bronchiectasis, r = 0.1;
r2 = 0.009; P > .05; y = 0.03x + 5.92), (b)
Bland–Altman analysis of agreement for
FDMRI and 3He MRI VDP (COPD,
bias = 16  9%; lower limit = 35%;
upper limit = 2% and bronchiectasis,
bias = 13  10%; lower limit = 32%;
upper limit = 6%), (c) FDMRI VDP linear
regression with CT RA950 (COPD, r = .80;
r2 = .64; P = .002; y = 0.59x + 2.10 and
bronchiectasis, r = 0.23; r2 = 0.05;
P > .05; y = .21x + 5.85), (d) FDMRI VDP
linear regression with 3He MRI apparent
diffusion coefficient (COPD, r = 0.71;
r2 = 0.51; P = .01; y = 28x + 5 and bronchi-
ectasis, r = .16; r2 = .03; P > .05; y = 9.4x +
2.9). Dotted lines = 95% confidence inter-
vals. ADC, apparent diffusion coefficient;
COPD, chronic obstructive pulmonary dis-
ease; CT, computed tomography; FDMRI,
free-breathing 1H magnetic resonance im-
aging; MRI, magnetic resonance imaging;
RA950, relative area of the lung with attenu-
ation values <950 HU; VDP, ventilation
defect percent.
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Figure 2 shows the linear correlation of FDMRI with 3He
MRI VDP and the agreement between measurements for
subjects with COPD and bronchiectasis. Although FDMRI
and 3He MRI VDP were significantly different, as shown in
Table 2, these measurements were strongly correlated in sub-
jects with COPD (r = .88; P = .0001), but not in those with
bronchiectasis (r = .1; P > .05). Bland–Altman analysis
showed a bias of 16  9% (95% confidence interval,
35% to 5%) for FDMRI (Fig 2b), and this bias increased
with increasing VDP for subjects with COPD. FDMRI
VDP was also strongly correlated with RA950 (r = .80;
P = .002) and 3He MRI ADC (r = .71; P = .01) for subjects
with COPD, both of which are well-established measure-
ments of emphysema (8,16).
Given the strong correlation between FDMRI and 3He
MRI VDP for subjects with COPD, we evaluated the spatial
relationships for ventilation and ventilation defects derived
from using both these methods. These data are shown in
Table 3 and for the subjects representative of COPD (S1
and S2) and bronchiectasis (S3 and S4) in Figure 3.
Table 3 provides mean DSC for FDMRI and 3He MRI
ventilation and ventilation defects. The DSC for FDMRI
and 3He MRI ventilation was 86% for both subject groups.
In a similar fashion, the spatial overlap of FDMRI ventila-
tion with lung regions >950 HU was 92% and 93% for
subjects with COPD and bronchiectasis, respectively. For
ventilation defects, the spatial relationship of FDMRI and
3He MRI ventilation defects was 20  17% and 14  9%
for subjects with COPD and bronchiectasis, respectively.
In subjects with COPD, the DSC for FDMRI ventilation
defects with lung regions <950 HU, reflective of emphy-
sema was 19  20%. For subjects with bronchiectasis, the
spatial overlap of FDMRI and lung regions <950 HU
(2  3%) was significantly lower than the spatial overlap of
FDMRI and 3He MRI ventilation defects (14 +/ 9%
P < .001).
Some of these spatial relationships are also shown in
Figure 3, where the regional similarities of FDMRI with
3He static ventilation images are visually apparent for subjects
with COPD (S1 and S2) and less obvious for those with bron-
chiectasis (S3 and S4). In particular for the subjects with bron-
chiectasis, there is little evidence of emphysema, and
therefore, there is negligible overlap between RA950 and
ventilation defects.
Table 4 summarizes the significant correlations for
FDMRI VDP with 3He MRI, CT, and pulmonary function
measurements for the COPD and bronchiectasis subgroups.
There were significant correlations for FDMRI VDP with
3He MRI VDP and ADC, Raw, and RA950 (P < .05) for
subjects with COPD. For subjects with bronchiectasis, there
was a significant correlation between FDMRI VDP and LA
(P < .05). For those with COPD, the FDMRI and 3He
MRI VDP correlations were not significantly different;
however, for subjects with bronchiectasis, there were signif-
icant differences.
DISCUSSION
In this proof-of-concept study, we evaluated 26 patients
including 12 subjects with COPD and another 14 with bron-
chiectasis and observed the following: 1) in all subjects,
FDMRI VDP was significantly less than 3He MRI VDP, 2)
in subjects with COPD but not in those with bronchiectasis,
FDMRI and 3He MRI ventilation and VDP were quantita-
tively correlated, and these values showed strong spatial rela-
tionships with one another and with RA950 maps, and 3) in
subjects with COPD only, there were significant and similar
correlations for FDMRI and 3He MRI VDP with pulmonary
function test and CT measurements.
In all subjects, FDMRI VDP was significantly less than 3He
MRI VDP. It is difficult to completely understand why
FDMRI VDP was significantly less and FDMRI ventilation
was significantly greater than 3He MRI measurements in all
subjects. However, one explanation may be derived from
the underlying principles of the two methods and how they
generate or capture ventilation information. Inhaled contrast
gas methods provide static breath-hold snapshots of where
the high-contrast inhaled gas travels to and resides during
the scanning period of 8–15 seconds. In this manner,
very high-contrast and signal-to-noise ventilation images
can be easily generated and processed. In contrast, but
similar to four-dimensional CT (4DCT) that produces
three-dimensional image data sets through time (39,40),
FDMRI generates ventilation contrast based on image signal
differences during the breathing cycle as air enters and
leaves the pulmonary system and tissue contracts and
expands. This is a more indirect approach that relies on
robust and accurate image processing methods to coregister
the dynamic free tidal-breathing 1H MRI. This method also
relies on the inherent image signal intensity and signal-to-
noise ratios of pulmonary images from a system that is
TABLE 3. Quantitative Spatial Relationships for FDMRI
Ventilation and Ventilation Defects
Mean DSC (SD)
All
(n = 26)
Bronchiectasis
(n = 14)
COPD
(n = 12)
Significant
Difference
(P Value)
Ventilation
FDMRI–3He
MRI, %
86 (5) 86 (4) 86 (7) .8
FDMRI–RA>950, % 92 (3) 93 (2) 92 (3) .5
Ventilation defects
FDMRI–3He
MRI, %
16 (13) 14 (9) 20 (17) .2
FDMRI–RA950, % 10 (16) 2 (3) 19 (20) .005
ADC, apparent diffusion coefficient; DSC, Dice similarity coefficient;
FDMRI, free-breathing 1H magnetic resonance imaging; MRI, mag-
netic resonance imaging; RA950, relative area <950 HU; RA>950,
relative area >950 HU; VDP, ventilation defect percent.
Significant difference between groups (P < .05) determined by the
analysis of variance.
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inherently air filled. In CT, the attenuation values for air as
compared to tissue provide significant contrast. However,
the contrast derived from the 1H signal changes are inherently
weak, and this certainly necessitates that the image processing
methods used be more complex and robust. Previous work
(41) explored the spatial and quantitative relationship of 3He
Figure 3. Spatial relationships of free-
breathing 1H magnetic resonance imaging
(FDMRI) with 3He MRI ventilation and
emphysema for representative subjects
with chronic obstructive pulmonary dis-
ease (COPD) and bronchiectasis. Left
panel: spatial overlap (green) of FDMRI
(magenta) and 3He MRI (aqua) ventilation
coregistered with 1H MRI and airway tree
in brown. Right panel: spatial overlap
(green) of FDMRI (magenta) ventilation de-
fects and relative area of the lung with
attenuation values <950 HU (RA950)
mask (yellow) coregisteredwith CT for sub-
jects with COPD (S1 and S2) and bronchi-
ectasis (S3 and S4). Dice coefficients for
FDMRI–3He MRI ventilation, S1 = 88%;
S2 = 86%; S3 = 91%; S4 = 84% and
FDMRI defects: RA950, S1 = 41%;
S2 = 56%; S3 = 1%; S4 = 0%. COPD,
chronic obstructive pulmonary disease;
FDMRI, free-breathing 1H magnetic reso-
nance imaging; RA950, relative area of the
lung with attenuation values <950 HU.
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MRI and 4DCT ventilation measurements in a proof-of-
concept demonstration in a small number of non–small cell
lung cancer patients. There was excellent spatial correspon-
dence for the ventilation maps derived using static MRI and
free-breathing CT imaging approaches with no significant
differences in ventilation. These results provided good
evidence that ventilation maps and measurements generated
using vastly different image acquisition and analysis methods,
as well as breathing maneuvers, provided similar regional and
quantitative ventilation information.
It is important to note that 3He MRI ventilation percent
and VDP are not independent measurements because these
simply sum to 100%. However, because here we are directly
comparing VDP, which is a relatively small volume and venti-
lation which is a large volume for both Fourier decomposition
(FD) and 3He MRI, we think it is important to use and
compare both values. This is especially important to show
spatial relationships such as the Dice similarity coefficient
that is highly dependent on the relative size of the compara-
tors. We think this is also important because the 3He ventila-
tion MRI depicts gas distribution, whereas the FDMRI
ventilation reflects the ventilation fundamental frequency
and signal intensity changes related to this value. Because of
this, spatial overlap analyses were conducted for both ventila-
tion maps and ventilation defect maps obtained using both
3He and FDMRI.
In subjects with COPD but not in those with bronchiec-
tasis, FDMRI and 3He MRI ventilation were quantitatively
and spatially related. In addition, FDMRI and 3He MRI
VDP were quantitatively correlated and showed strong spatial
relationships with RA950 maps—those regions that reflected
emphysematous destruction or air in CT images. We
were surprised to observe such differences in the spatial and
quantitative correlations for FDMRI and 3He MRI in sub-
jects with COPD as compared to those with bronchiectasis.
One explanation can be derived from the presence of thick
mucus (which appears as greater 1H signal intensity relative
to that of lung parenchyma) in the airways and parenchyma
in bronchiectasis that may lead to registration error. To
generate FDMRI ventilation images, registration algorithms
must account for the movement of the diaphragm, and any
registration error will result in regions of high signal intensity
(eg, mucus pooling in subjects with bronchiectasis) oscillating
at the same frequency as respiration. This registration error
can result in apparently increased ventilation, which may or
may not accurately reflect truly ventilated regions. Thus, in
subjects with bronchiectasis, there may be regions that appear
as ventilation in FDMRI that are in fact not ventilated because
of misalignment of the mucus’ boundaries via the deformable
registration process. We must acknowledge that all three im-
aging methods measure very different physical parameters.
For example, although CT provides a measurement of
regional lung tissue density, 3He MRI provides a functional
estimate of pulmonary ventilation and alveolar dimensions us-
ing diffusion-weighted imaging. FDMRI on the other hand,
provides an estimate of ventilation by quantifying the signal
intensity contributions throughout the compression and
expansion of the lung parenchyma via the cardiac and the res-
piratory cycles. However, we recently showed that in subjects
with COPD, 3He MRI ventilation defects often colocalize
with large emphysematous bullae (42). In fact, we previously
observed this in patients with advanced emphysema and
because of this work hypothesized that this spatial colocaliza-
tion was related to the long time constants for filling of
emphysematous bullae and not airways disease. Here, and in
light of these previous findings, we directly evaluated the
TABLE 4. Pearson Correlations for FDMRI and 3He MRI
FDMRI VDP % 3He MRI VDP % Fisher z0
Bronchiectasis (n = 14) COPD (n = 12) Bronchiectasis (n = 14) COPD (n = 12) B C
r/P Value r/P Value r/P Value r/P Value P Value P Value
FEV1, %pred 0.41/.1 0.22/.5 0.73/.003 0.42/.2 .001 .6
FVC, %pred 0.31/.3 0.20/.5 0.60/.02 0.04/.9 .02 .7
RV/TLC, % 0.31/.3 0.19/.6 0.65/.02 0.07/.8 .01 .8
Raw, %pred 0.23/.4 0.60/.04 0.47/.09 0.56/.06 .08 .9
DLCO, %pred 0.08/.8 0.57/.05 0.36/.2 0.61/.04 .3 .9
FDMRI ventilation, % 1/<.001 1/<.001 0.1/.7 0.88/<.001 <.001 <.001
FDMRI VDP, % —/— —/— 0.1/.7 0.88/<.001 — —
3He MRI ventilation, % 0.1/.7 0.88/<.001 1/<.001 1/<.001 <.001 <.001
3He MRI VDP, % 0.10/.7 0.88/<.001 —/— —/— — —
3He MRI ADC, cm2/s 0.16/.6 0.71/.01 0.35/.2 0.76/.004 .6 .8
CT RA950, % 0.23/.4 0.80/.002 0.04/.9 0.72/.008 .6 .7
CT WA, % 0.35/.2 0.07/.8 0.29/.3 0.18/.6 .1 .8
CT LA, mm2 0.58/.03 0.43/.2 0.09/.7 0.59/.04 .08 .6
ADC, apparent diffusion coefficient; DLCO, diffusing capacity for carbon monoxide; FEV1, forced expiratory volume in 1 second; FDMRI, free-
breathing 1H magnetic resonance imaging; FVC, forced vital capacity; LA, lumen area; %pred, percent of predicted value; MRI, magnetic reso-
nance imaging; r, Pearson correlation coefficients; Raw, airways resistance; RA950, relative area of the lungwith attenuation <950HU; RV/TLC,
residual volume/total lung capacity; VDP, ventilation defect percent; WA, wall area.
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spatial colocalization of emphysematous regions with FDMRI
and 3He MRI ventilation defects. The spatial relationships
observed for FDMRI and 3He MRI ventilation defects with
RA950 in the present study suggest that in patients with
emphysema, ventilation defects generated using FDMRI
may also be derived to the long time constants for lung filling.
Our findings further support the notion that these methods
(ie, FDMRI, 3He MRI, and CT), although very different,
are probing and interrogating similar functional, but likely
not structural information, in subjects with COPD. It appears
that a free-breathing method like FDMRI, shows some
dependence on the very long time constants for filling emphy-
sematous bullae, and this finding should be considered when
using FDMRI for COPD imaging.
Finally, only in subjects with COPD, there were significant
and similar correlations for FDMRI and 3He MRI VDP with
pulmonary function test and CT measurements. These are
important findings that further support and suggest that
both methods provide similar functional information in sub-
jects with COPD even though they are very unique methods.
In contrast, for those with bronchiectasis, there was a signifi-
cant correlation between FDMRI VDP and airway LA. This
suggests that elevated LA (corresponding to dilated airways)
may be related to low proton density.
We recognize and acknowledge that this work was limited
by the relatively small sample size. In addition, we studied
mainly subjects with moderate COPD (8 of 12 subjects
with GOLD grade II or III), and given our understanding
of the heterogeneity of patients with COPD, caution should
be used when extrapolating our results to a broader COPD
group. Fourier decomposition has recently emerged as a pul-
monary functional MRI method, with the promise of serial
lung function measurements without a dependence on polar-
ized or other inhaled gases or multinuclear capabilities. This
opens up the opportunity for functional lung imaging on con-
ventional MRI scanners—available more universally, albeit
the final measurements are dependent on more sophisticated
image processing methods. It should be noted that one of
the challenges associated with pulmonary proton MRI
methods is the weak pulmonary proton signal intensity that
is further diminished at higher field strengths because of the
relationship between field strength and T2* effects. Previous
pilot and development studies at 1.5 T have shown qualitative
agreement for regional ventilation and perfusion measure-
ments with the clinical reference standard SPECT/CT (28).
Moreover, recent studies have also demonstrated the repro-
ducibility of FDMRI ventilation-weighted and perfusion-
weighted images in healthy volunteers (32). Finally
FDMRI-to-3HeMRI comparisons in animals showed similar
regional abnormalities including pulmonary embolism, atel-
ectasis, and air trapping (30).
To our knowledge, there has been no prospective compar-
ison of FDMRI to 3He MRI at 3 T in subjects with COPD
and bronchiectasis. Consistent with previous studies, we
showed similar regional ventilation abnormalities using
FDMRI and 3He MRI in subjects with COPD, and these
appear to be dominated by the presence of regional emphyse-
matous bullae. In summary, FDMRI and 3He MRI ventila-
tion and VDP were strongly correlated in subjects with
COPD but not in those with bronchiectasis. Only in subjects
with COPD, FDMRI ventilation defects were also spatially
related with 3He MRI ventilation defects and CT measure-
ments of emphysema.
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